AI Generated Image
UPS to invest $48 million in cold facilities amid GLP-1 boom
CNBC • • general
Key Points:
- UPS is investing $48 million in 27 temperature-controlled facilities across the Americas, Europe, and Asia to enhance its healthcare logistics capabilities amid growing demand for temperature-sensitive medicines.
- The investment aims to improve the speed and reliability of transporting pharmaceuticals like GLP-1 drugs, which require strict temperature control to maintain efficacy.
- The market for temperature-sensitive biologics is expected to grow at an 8.3% annual rate through 2033, reaching an estimated value of $39.1 billion, highlighting the increasing importance of cold-chain logistics.
- UPS executives emphasized the critical role of their enhanced cold-chain infrastructure in reducing vaccine wastage and ensuring the safe delivery of innovative treatments worldwide.
- Healthcare remains a top priority and growth area for UPS, with the company recently achieving its first $3 billion healthcare revenue quarter and committing to further expansion in this sector.
